'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease
Open Access
- 25 July 2007
- journal article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 6 (1) , 19
Abstract
The association between TGF-β1 levels and long-term major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) is controversial. No study specifically addressed patients with CAD and diabetes mellitus (DM). The association between TGF-β1 levels and long-term major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD) is controversial. No study specifically addressed patients with CAD and diabetes mellitus (DM).Keywords
This publication has 28 references indexed in Scilit:
- Inflammation in atherosclerosisNature, 2002
- Prognostic significance of plasma concentrations of transforming growth factor-β in patients with coronary artery diseaseCoronary Artery Disease, 2002
- Transforming growth factor (TGF)‐β1 inversely related to vascular cell adhesion molecule‐1 in postmenopausal women with coronary artery disease. A possible mechanism for the putative cardioprotective role of TGF‐β1?Journal of Internal Medicine, 2002
- Low TGF-β1 serum levels are a risk factor for atherosclerosis disease in ESRD patientsKidney International, 2002
- TGF-β reduced binding of high-density lipoproteins in murine macrophages and macrophage-derived foam cellsAtherosclerosis, 2001
- The significance of CD105, TGFβ and CD105/TGFβ complexes in coronary artery diseaseAtherosclerosis, 2000
- Circulating transforming growth factor β1 and coronary artery diseaseCardiovascular Research, 1997
- Altered plasma levels of cytokines in patients with ischemic heart diseaseCoronary Artery Disease, 1997
- Production of Endothelin-1 in Vascular Endothelial Cells Is Regulated by Factors Associated with Vascular InjuryGerontology, 1992
- Effects of transforming growth factor-β1 on growth of aortic smooth muscle cells Influences of interaction with growth factors, cell state, cell phenotype, and cell cycleAtherosclerosis, 1991